431 related articles for article (PubMed ID: 23859570)
21. Association of SCN1A, SCN2A, and UGT2B7 Polymorphisms with Responsiveness to Valproic Acid in the Treatment of Epilepsy.
Lu Y; Su Q; Li M; Dayimu A; Dai X; Wang Z; Che F; Xue F
Biomed Res Int; 2020; 2020():8096235. PubMed ID: 32185219
[TBL] [Abstract][Full Text] [Related]
22. SCN1AIVS5-91G>A polymorphism is associated with susceptibility to epilepsy but not with drug responsiveness.
Kumari R; Lakhan R; Kumar S; Garg RK; Misra UK; Kalita J; Mittal B
Biochimie; 2013 Jun; 95(6):1350-3. PubMed ID: 23466530
[TBL] [Abstract][Full Text] [Related]
23. RORA gene rs12912233 and rs880626 polymorphisms and their interaction with SCN1A rs3812718 in the risk of epilepsy: a case-control study in Malaysia.
Haerian BS; Sha'ari HM; Tan HJ; Fong CY; Wong SW; Ong LC; Raymond AA; Tan CT; Mohamed Z
Genomics; 2015 Apr; 105(4):229-36. PubMed ID: 25668517
[TBL] [Abstract][Full Text] [Related]
24. Whole gene duplication of SCN2A and SCN3A is associated with neonatal seizures and a normal intellectual development.
Thuresson AC; Van Buggenhout G; Sheth F; Kamate M; Andrieux J; Clayton Smith J; Soussi Zander C
Clin Genet; 2017 Jan; 91(1):106-110. PubMed ID: 27153334
[TBL] [Abstract][Full Text] [Related]
25. SCN1A variations and response to multiple antiepileptic drugs.
Yip TS; O'Doherty C; Tan NC; Dibbens LM; Suppiah V
Pharmacogenomics J; 2014 Aug; 14(4):385-9. PubMed ID: 24342961
[TBL] [Abstract][Full Text] [Related]
26. GAPDH-mediated posttranscriptional regulations of sodium channel Scn1a and Scn3a genes under seizure and ketogenic diet conditions.
Lin GW; Lu P; Zeng T; Tang HL; Chen YH; Liu SJ; Gao MM; Zhao QH; Yi YH; Long YS
Neuropharmacology; 2017 Feb; 113(Pt A):480-489. PubMed ID: 27816501
[TBL] [Abstract][Full Text] [Related]
27. Characterization of 5' untranslated regions of the voltage-gated sodium channels SCN1A, SCN2A, and SCN3A and identification of cis-conserved noncoding sequences.
Martin MS; Tang B; Ta N; Escayg A
Genomics; 2007 Aug; 90(2):225-35. PubMed ID: 17544618
[TBL] [Abstract][Full Text] [Related]
28. SCN1A Polymorphisms and Haplotypes Are Associated With Valproic Acid Treatment Outcomes in Chinese Children With Epilepsy.
Zhu J; Lu J; Shen X; He Y; Xia H; Li W; Guo H; Zhang J; Fan X
Pediatr Neurol; 2023 Sep; 146():55-64. PubMed ID: 37451178
[TBL] [Abstract][Full Text] [Related]
29. Association between Genetic Polymorphism of
Tang HX; Ho MD; Vu NP; Cao HV; Ngo VA; Nguyen VT; Nguyen TD; Nguyen TD
Medicina (Kaunas); 2024 Apr; 60(4):. PubMed ID: 38674283
[No Abstract] [Full Text] [Related]
30. SCN1A, ABCC2 and UGT2B7 gene polymorphisms in association with individualized oxcarbazepine therapy.
Ma CL; Wu XY; Jiao Z; Hong Z; Wu ZY; Zhong MK
Pharmacogenomics; 2015; 16(4):347-60. PubMed ID: 25823783
[TBL] [Abstract][Full Text] [Related]
31. Mutations in the sodium channel genes SCN1A, SCN3A, and SCN9A in children with epilepsy with febrile seizures plus(EFS+).
Ma H; Guo Y; Chen Z; Wang L; Tang Z; Zhang J; Miao Q; Zhai Q
Seizure; 2021 May; 88():146-152. PubMed ID: 33895391
[TBL] [Abstract][Full Text] [Related]
32. Prevalence of SCN1A mutations in children with suspected Dravet syndrome and intractable childhood epilepsy.
Wang JW; Shi XY; Kurahashi H; Hwang SK; Ishii A; Higurashi N; Kaneko S; Hirose S;
Epilepsy Res; 2012 Dec; 102(3):195-200. PubMed ID: 23195492
[TBL] [Abstract][Full Text] [Related]
33. Comparison and optimization of in silico algorithms for predicting the pathogenicity of sodium channel variants in epilepsy.
Holland KD; Bouley TM; Horn PS
Epilepsia; 2017 Jul; 58(7):1190-1198. PubMed ID: 28518218
[TBL] [Abstract][Full Text] [Related]
34. The association of SCN1A p.Thr1067Ala polymorphism with epilepsy risk and the response to antiepileptic drugs in Slovenian children and adolescents with epilepsy.
Bertok S; Dolžan V; Goričar K; Podkrajšek KT; Battelino T; Rener-Primec Z
Seizure; 2017 Oct; 51():9-13. PubMed ID: 28753467
[TBL] [Abstract][Full Text] [Related]
35. Association between SCN1A and SCN2A mutations and clinical/EEG features in Chinese patients from epilepsy or severe seizures.
Kong Y; Yan K; Hu L; Wang M; Dong X; Lu Y; Wu B; Wang H; Yang L; Zhou W
Clin Chim Acta; 2018 Aug; 483():14-19. PubMed ID: 29649454
[TBL] [Abstract][Full Text] [Related]
36. Infantile epilepsy associated with mosaic 2q24 duplication including SCN2A and SCN3A.
Vecchi M; Cassina M; Casarin A; Rigon C; Drigo P; De Palma L; Clementi M
Seizure; 2011 Dec; 20(10):813-6. PubMed ID: 21893419
[TBL] [Abstract][Full Text] [Related]
37. Associations between CYP3A4, CYP3A5 and SCN1A polymorphisms and carbamazepine metabolism in epilepsy: A meta-analysis.
Zhao GX; Zhang Z; Cai WK; Shen ML; Wang P; He GH
Epilepsy Res; 2021 Jul; 173():106615. PubMed ID: 33756436
[TBL] [Abstract][Full Text] [Related]
38. SCN3A deficiency associated with increased seizure susceptibility.
Lamar T; Vanoye CG; Calhoun J; Wong JC; Dutton SBB; Jorge BS; Velinov M; Escayg A; Kearney JA
Neurobiol Dis; 2017 Jun; 102():38-48. PubMed ID: 28235671
[TBL] [Abstract][Full Text] [Related]
39. Association of polymorphisms in EPHX1, UGT2B7, ABCB1, ABCC2, SCN1A and SCN2A genes with carbamazepine therapy optimization.
Hung CC; Chang WL; Ho JL; Tai JJ; Hsieh TJ; Huang HC; Hsieh YW; Liou HH
Pharmacogenomics; 2012 Jan; 13(2):159-69. PubMed ID: 22188362
[TBL] [Abstract][Full Text] [Related]
40. Genetic factors associated with drug-resistance of epilepsy: relevance of stratification by patient age and aetiology of epilepsy.
Sánchez MB; Herranz JL; Leno C; Arteaga R; Oterino A; Valdizán EM; Nicolás JM; Adín J; Armijo JA
Seizure; 2010 Mar; 19(2):93-101. PubMed ID: 20064729
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
